Get started
Author

Alessandra Ariaudo

A UHPLC–MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma
2016 · Alessandra Ariaudo, Fabio Favata, et al. · Journal of Pharmaceutical and Biomedical Analysis · 123
PDF
HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)
2011 · Antonio D’Avolio, Marco Simiele, et al. · Journal of Pharmaceutical and Biomedical Analysis · 76
PDF
UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma
2017 · Marco Simiele, Alessandra Ariaudo, et al. · Journal of Pharmaceutical and Biomedical Analysis · 52
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation
2013 · Francesco G. De Rosa, Silvia Corcione, et al. · International Journal of Antimicrobial Agents · 50
PDF
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS
2012 · L. Baietto, A. D'Avolio, et al. · Journal of Antimicrobial Chemotherapy · 43
Development and validation of an UPLC–PDA method to quantify daptomycin in human plasma and in dried plasma spots
2013 · Lorena Baietto, Antonio D’Avolio, et al. · Journal of Pharmaceutical and Biomedical Analysis · 42
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots
2013 · Lorena Baietto, Antonio D’Avolio, et al. · Journal of Chromatography B · 40
A LC–MS method to quantify tenofovir urinary concentrations in treated patients
2015 · Marco Simiele, Chiara Carcieri, et al. · Journal of Pharmaceutical and Biomedical Analysis · 27
Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure
2017 · A. Calcagno, N. Pagani, et al. · Journal of Antimicrobial Chemotherapy · 15
PDF
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia
2013 · Silvia De Francia, Antonio D'Avolio, et al. · Therapeutic Drug Monitoring · 13
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study
2018 · Jessica Cusato, Amedeo De Nicolò, et al. · Journal of Antimicrobial Chemotherapy · 12
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs
2018 · Jessica Cusato, Lucio Boglione, et al. · Cancer Chemotherapy and Pharmacology · 11
Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study
2017 · Jessica Cusato, Amedeo De Nicolò, et al. · Journal of Antimicrobial Chemotherapy · 8
PDF
Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis
2016 · Marco Merli, Laura Galli, et al. · Journal of Antimicrobial Chemotherapy · 8
PDF
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients
2018 · Jessica Cusato, Amedeo De Nicolò, et al. · Infection Genetics and Evolution · 4
Pharmacogenomic influence on sepsis outcome in critically ill patients.
2017 · Sarah Allegra, Giovanna Fatiguso, et al. · PubMed · 3
Vitamin D Pathway Gene Polymorphisms Affecting Daclatasvir Plasma Concentration at 2 Weeks and 1 Month of Therapy
2018 · Jessica Cusato, Amedeo De Nicolò, et al. · Pharmacogenomics · 2
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations
2017 · Lucio Boglione, Amedeo De Nicolò, et al. · Digestive and Liver Disease · 2
Single-Nucleotide Polymorphisms of ABCB1 Gene Influence Intracellular Concentrations of Dasatinib
2012 · Antonio D'Avolio, Silvia De Francia, et al. · Blood · 2
Development and validation of a semi-automated hybrid immunocapture liquid chromatography-mass spectrometry method to quantify LALA-mutated biotherapeutics in mouse plasma
2026 · Vittoria Papa, Ilse De Salve, et al. · European Journal of Pharmaceutical Sciences
Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study
2017 · A. De Nicolò, L. Boglione, et al. · Digestive and Liver Disease
Higher simeprevir plasma exposure when co-administered with sofosbuvir leads to higher risk of dermatological toxicity
2016 · A. De Nicolò, L. Boglione, et al. · Digestive and Liver Disease
A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect"
2016 · Antonio D’Avolio, Alessandra Ariaudo, et al. · Institutional Research Information System University of Turin (University of Turin)
New UPLC-MS/MS method for simultaneous determination of dolutegravir, elvitegravir, rilpivirine and other 14 HIV drugs in human plasma
2014 · Marco Simiele, Alessandra Ariaudo, et al. · Institutional Research Information System University of Turin (University of Turin)
Pharmacogenetic Determinants of Plasmatic and Intracellular Tyrosine Kinase Inhibitors
2014 · Carmen Fava, Jessica Cusato, et al. · Institutional Research Information System University of Turin (University of Turin)
Works count: 34
Citation count: 533
H-index: 11
I10-index: 12
Year
Topic
Type